ArticlePhysiological reports2017

Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine.

Ebru S Selen Alpergin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.